60% of Lats1−/− mice die in utero but 14.3% of surviving female Lats1−/− mice develop fibrosarcomas by 4–10 months. Adding carcinogen exposure decreases latency and increases penetrance to 83%. The gene discussed is LATS1; the disease is fibrosarcoma.